Gain Therapeutics Inc

Market Cap

$84M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.68-$1.50 (-47.17%)

Jul 15, 2026

52W High $4.1852W Low $1.44

Company Details

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform M...

Leadership

Khalid Islam Ph.D.Founder

Chairman & Founder

Gene Mack M.B.A.

President, CEO & Director

Gianluca Fuggetta

Senior VP of Finance & Principal Financial Officer

Terenzio Ignoni Pharm.D.

Senior Vice President of Technical Operations

Joanne Taylor Ph.D.

Senior Vice President of Research

Jonas Hannestad M.D., Ph.D.

Chief Medical Officer

IPO Date

Mar 18, 2021

Website

gaintherapeutics.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$21M

EPS (Diluted)

Free Cash Flow

-$19M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee